- Sort by Average rating
- Display 45 Products per page
Published: April 30, 2024 | Price: $5,000.00 – $10,500.00
Authoritative market research on cell therapy, gene therapy, and RNA therapy analyzing markets by disease type Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body's immune system. Recent years have seen an increase in new therapies and the pipeline indicates this trend will continue. A large range of therapeutic areas from oncology to cardiology have seen rapidly proliferating clinical trials. Cell...Published: April 24, 2024 | Price: $10,500.00
NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests report, World Market for Molecular Diagnostics report or Molecular Point-of-Care (mPOC) report. All in any edition. This is because this is a quarterly update to markets covered in these reports. The most up-to-date information for company-wide success. Buyers will receive data updates after each financial quarter for one year (for a total of four updates). These comprehensive updates come in an Excel spreadsheet...Published: April 23, 2024 | Price: $7,000.00 – $14,000.00
NOW IN ELEVEN EDITIONS—The Worldwide Market for Point-of-Care (POC) Diagnostic Tests forecasts the POC market through 2028. Lab-based analyzers in hospitals and reference labs are the cornerstone of revenues in the in vitro diagnostics (IVD) industry. However, the point-of-care (POC) segment is seen as a key growth area. Point-of-care refers to tests that can provide meaningful results during a provider visit or in the patient's home. Over the past two decades, Kalorama Information has observed that POC tests present significant...Published: March 27, 2024 | Price: $5,000.00 – $10,500.00
Diagnostic testing has become a fundamental aspect of healthcare, aiding physicians in diagnosing conditions and determining treatments. Despite a decline in COVID-19 testing affecting total revenues, core diagnostic segments have generally experienced growth. Factors such as new products, changes in global health spending, regulatory shifts, and disease trends contribute to a constantly changing market, yet one that remains resilient. Key growing segments attracting industry attention include next-generation sequencing (NGS), personalized medicine, and mass spectrometry. Immunochemistry, point-of-care (POC) testing, and molecular...Published: March 22, 2024 | Price: $5,000.00 – $10,500.00
What’s Included One Report Covering 30 Countries Sizing for 20 Important IVD Market Segments Segments Estimated for Each Country Forecasts to 2028 for Each Segment Updated Quarterly (4 updates annually) to Reflect Market Changes Over 2800 Data Points About the Report With over two decades of experience in publishing in vitro diagnostic (IVD) market research, Kalorama Information understands the importance of global coverage and the need for more detailed geographic analysis. While regional coverage is valuable, it often falls short...Published: March 7, 2024 | Price: $5,000.00 – $10,500.00
Molecular point-of-care (mPOC) diagnostic solutions offer enhanced sensitivity and specificity compared to existing near-patient and rapid tests. They expand diagnostic capabilities in critical care units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology. Kalorama Information has been covering mPOC on a regular basis since 2013. Our latest report, The Market and Future Potential for Molecular Point-of-Care (mPOC),...Published: February 26, 2024 | Price: $5,000.00 – $10,500.00
The IVD Market in South Korea, 2024 offers a comprehensive overview of the in vitro diagnostics (IVD) market in South Korea and the factors shaping it. The report presents South Korea's IVD revenues for 2023 and forecasts for 2028, segmented into clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC), and histology/cytology. Included in the report are trends influencing the industry and country-level data including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences. The report...Published: February 22, 2024 | Price: $5,000.00 – $10,500.00
Vaccines offer long-term or permanent immunity against diseases. They have been a cornerstone of preventive medicine for over 70 years, stimulating an immune response to specific diseases. The widespread adoption of effective vaccines has led to the near-elimination of many deadly diseases, making vaccination one of the greatest public health achievements of the 20th century. Thanks to public vaccination programs, vaccine-preventable diseases and related deaths are now rare in developed nations and decreasing globally. Smallpox has been eradicated, polio eliminated...Published: March 21, 2024 | Price: $4,995.00 – $9,995.00
In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually. In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including: Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities A comprehensive view of the IVD market with test categories covered and company briefs M&A activities, selected partnerships & collaborations, partnership deals, and more Industry & region watch to help tailor strategies Analysis of news and events and reporting on...Published: January 22, 2024 | Price: $5,000.00 – $10,500.00
Diagnostic testing plays a crucial role in animal healthcare, offering veterinarians a diverse range of tests for disease identification and monitoring. The efficacy of diagnostic testing relies on swift, reliable, and accurate methods, facilitating informed diagnoses. Despite various challenges, the veterinary diagnostics market has shown consistent growth and is forecasted to continue on this trajectory. This sector presents a rapidly expanding market opportunity for in vitro diagnostic (IVD) companies and others who can leverage the ongoing demand to ensure agricultural...Published: December 29, 2023 | Price: $5,000.00 – $10,000.00
Liquid biopsies have emerged as a minimally invasive diagnostic tool, analyzing tumor-derived materials circulating in biological fluids to offer valuable information for cancer diagnosis, treatment, and monitoring. While tissue biopsies and imaging techniques remain standard in solid tumor diagnosis, liquid biopsies present an alternative or complementary approach, addressing some of the limitations and risks associated with traditional methods. Key applications of liquid biopsy testing in clinical oncology include: Early Detection and Diagnosis/Screening: Identifying cancer at an early stage. Alternative Testing...Published: December 19, 2023 | Price: $3,750.00 – $7,500.00
Recent years saw molecular diagnostics emerge as the fastest growing segment within the global in vitro diagnostics (IVD) market. The market was both boosted and challenged in unexpected ways by COVID-19. But where does the multi-billion-dollar molecular diagnostic market stand post pandemic? This new report by Kalorama Information, The World Market for Molecular Diagnostics, 12th Edition, reveals that post-pandemic the market remains ripe with opportunity, notably in the areas of infectious diseases, cancer, and transplant diagnostics. Global demand persists, with...Published: December 8, 2023 | Price: $5,000.00 – $10,000.00
While the concepts of gene therapy and cell therapy have been investigated for decades, there were major challenges in the early years. Through incremental progress, and the gradual introduction of enabling tools such as CRISPR and next-generation sequencing (NGS), cell and gene therapy has emerged into a highly active area. There are now many approved therapies with proven track records. As the technologies have lowered the barriers to entry for the industry, over 1,500 therapy or tools companies have been...Published: November 29, 2023 | Price: $5,000.00 – $10,000.00
In recent decades, the introduction of various new genetic technologies for research use and diagnostics has revolutionized many areas and opened new frontiers in healthcare. For example, next-generation sequencing (NGS) technologies have become widely used in genetic diseases, and have grown rapidly in oncology, due to the comprehensive insights they can provide at a relatively low cost. While older, PCR continues to be innovated and remains a central tool in molecular diagnostics laboratories of all kinds, and in situ hybridization...Published: November 27, 2023 | Price: $5,000.00 – $10,000.00
Telehealth and remote patient monitoring have become integral to improving health conditions and preventing health complications. The transformations observed during the pandemic have bolstered telemedicine and, consequently, remote patient monitoring, instilling confidence in virtual patient assessment and access to advanced technological monitoring. Since January 2019, remote patient monitoring has experienced a significant surge, and current telehealth systems are leveraging key technologies increasingly prevalent in the health industry to foster further growth. Kalorama Information analyzes these trends and more in Remote...Published: November 7, 2023 | Price: $3,750.00 – $7,500.00
In vitro diagnostic (IVD) testing is getting back to regular business and continues to be a driving force in the practice of medicine. It has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. COVID-19 testing continues to decline but is still a factor in total revenues for 2023. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors...Published: October 25, 2023 | Price: $5,000.00 – $10,000.00
The medical device industry, commonly referred to as the medtech industry, plays a pivotal role within the broader healthcare sector. This industry undergoes continuous evolution due to ongoing advancements in technology, equipment, diagnostic tools, and medical devices. These innovations have the profound impact of extending and enhancing the lives of patients, promoting longevity and well-being. However, the medical device industry faces distinctive challenges, primarily characterized by stringent regulations across the globe, as discussed in the regulatory section of this report....Published: October 18, 2023 | Price: $6,000.00 – $12,000.00
Laboratory information systems (LIS), also known as laboratory information management systems (LIMS), are data and information management systems designed for industrial and healthcare-related laboratories, including clinical and analytical laboratories. These include research and development labs, in-process testing labs and quality assurance labs. This new report from Kalorama Information, World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027, examines the current and potential world opportunity for healthcare laboratory information system (LIS) software, hardware, and implementation....Published: September 22, 2023 | Price: $6,000.00 – $12,000.00
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama Information’s In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests and the future potential. In the process, pricing analysis is also performed. This report...Published: September 8, 2023 | Price: $5,000.00 – $10,000.00
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...Published: August 24, 2023 | Price: $8,750.00 – $17,500.00
"The most trusted and essential report on the global IVD industry." For Two Decades, One Volume Has Offered Complete Coverage of the IVD Industry The 16th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests is a must have for anyone interested or involved in the IVD industry. Having a guide for the state of IVD and its future is a vital part of making well-informed decisions. The 16th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic...Published: July 13, 2023 | Price: $3,750.00 – $7,500.00
A variety of demographic, business, and government trends are contributing to rising out-of-pocket (OOP) healthcare expenses in the United States. Out-of-Pocket Healthcare Expenditures in the United States, 6th Edition examines these trends in detail, focusing on the financial aspects of OOP spending growth and quantifying the growth of OOP spending with forecasts of total expenditures and specialized healthcare financing. Total Expenditures The report examines past, current, and future levels of U.S. out-of-pocket healthcare expenditures both in total and as specific sub-groups (by type,...Published: June 6, 2023 | Price: $5,000.00 – $10,000.00
This new Kalorama Information report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023, examines a range of both at-home tests and home collection tests. The At-Home in vitro diagnostic (IVD) testing market is comprised of IVD tests that can be purchased at the local store or on the Internet where the patient gathers the specimen and results are displayed usually within minutes. Generally, these are lateral flow technology or dip stick methods. [caption id="attachment_19849"...Published: May 22, 2023 | Price: $5,000.00 – $10,000.00
This report, Kalorama's Cell and Gene Deals and Market Analysis, tracks the dealmaking and market opportunity in cell and gene therapy. The report includes specific details of 1000+ deals from 2022-2023. A lot of attention is being given to the areas related to cell and gene therapy (CGT) recently. Kalorama's CGT deals amounted to a staggering $40 billion in 2022. Understanding the deals that have been made, who is making them, and what the specific details are is critical to...Published: May 16, 2023 | Price: $5,000.00 – $10,000.00
Your Resource for Business Planning in the Clinical Laboratory Market What's the size of the service market for clinical testing? What type of tests are selling? Where is this market going next five years? Which companies will earn those revenues? Where is growth coming from? How will LDT regulation affect the market? What are companies planning with COVID-19 largely endemic? These questions and more are answered in Kalorama's Clinical Laboratory Services report. laboratories are the workhorse of diagnostic services for the...Published: April 24, 2023 | Price: $5,000.00 – $10,000.00
Covid-19 testing has been at the forefront in battling the pandemic. However, as the pandemic recedes and becomes more endemic, what will happen to the ever-changing COVID-19 testing market? Kalorama Information answers this question and more in COVID-19 Testing Markets, 2023. The pandemic has been a learning curve for all parties to invest in diagnostic systems, as COVID-19 aptly pointed out. Notably, the pandemic reinforced the importance of testing and a significant number of companies are increasing their development of...Published: April 13, 2023 | Price: $6,000.00 – $12,000.00
The point-of-care diagnostics market has long been the opportunity market within IVD. Kalorama publishes a full-scope market research study annually on point of care (POC) devices that can test near the patient for maximum benefit to healthcare encounters. While tests run on lab-based analyzers, remain the bedrock of IVD revenues, point of care has always been seen as the growth area. There are more companies in the point of care market, and it is a top segment of investment. Now...Published: April 6, 2023 | Price: $3,750.00 – $7,000.00
SKU 23-708: There is a nearly $10 billion-dollar market for hematology and coagulation IVD testing. Increasingly growth is driven by new technologies, the aging population, and the demand for decentralized testing. This report provides: Market sizing for Hematology IVD and Coagulation IVD Markets for Decentralized and Lab-based Segments. Forecasts to 2027 Market Share Country Markets for Hematology (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Spain, Turkey, United Kingdom, United States) Country Markets for Coagulation (Australia, Brazil, Canada, China,...Published: April 3, 2023 | Price: $5,000.00 – $10,000.00
The Market for Single Cell Analysis in Genomics: Next-Generation Sequencing and Other Technology, 2023-2027 focuses on the market for single cell genomics products. Analyzed are the hardware, service of the hardware, software, and consumables included for the sequencing step and other types of downstream analysis. Single cell RNA-seq enables new types of analyses, for instance: understanding tumour heterogeneity and clonal evolution (including studying lineage analysis, cancer stem cells, and drug-resistant and metastatic clones), understanding complex tissues (e.g. neural tissues), high resolution...Published: March 17, 2023 | Price: $3,750.00 – $7,500.00
Diagnostic testing continues to be a valuable resource to help physicians arrive at a diagnosis. Additionally, it has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. Now, in the aftermath of the COVID-19 pandemic, new products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture but one that remains resilient. Ultimately, the...Published: October 27, 2023 | Price: $5,000.00 – $10,000.00
In vitro diagnostics is a global market estimated to consist of over $120 billion. With less than half that revenue earned in the United States, an assessment of regional and country IVD markets is needed for successful business planning. Kalorama's 30 Country IVD Market Atlas report is designed to provide you with international market detail at the country-level to help improve your forecast modeling and planning. Whether you need Latin America, Middle East, APAC or Eastern Europe, this report has...Published: February 7, 2023 | Price: $5,000.00 – $10,000.00
This report is an essential tool for understanding the size and growth opportunity in molecular POC. Molecular point of care (mPOC) has gone from novel trend to significant contributor to the market. The instruments sold by Abbott, BioMérieux, Cepheid and increasingly, a host of other companies, are a significant contributor to the IVD POC market. Knowing these markets is essential to knowing the opportunity in point of care testing and microbiology IVD. Since 2013, Kalorama has been producing a dedicated...Published: January 30, 2023 | Price: $5,000.00 – $10,000.00
The World Market for Veterinary Diagnostics, 6th Edition examines the worldwide veterinary diagnostics market through the performance of its two component markets of companion animal (pets) and food animal diagnostics. The report provides analysis of major veterinary disease markets as well as overall market performance and development. Data points provided include: Total Global Animal Diagnostic Testing Market, 2022-2027 (in millions $ at manufacturer level) Global Veterinary Diagnostic Testing Market Share by Region 2022 (US, Europe, Latin America, Asia Pacific, RoW)...Published: January 23, 2023 | Price: $5,000.00 – $10,000.00
This report, The Market for In Vitro Diagnostic (IVD) Tests in Latin America, focuses on the market for reagents and instruments in the most important countries of the region. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis; the countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Nicaragua, Panama, Paraguay, and Uruguay were also considered to provide a complete overview of the region. Combined, these...Published: January 9, 2023 | Price: $5,000.00 – $10,000.00
This report analyzes trends in global demand for in vitro diagnostic (IVD) products used in physicians’ office laboratories. Specific products consist of reagents, test kits, standards and controls, and instruments and systems based on immunoassay, clinical chemistry, hematology, molecular, microbiology, and coagulation technologies. Physicians’ office laboratories are defined as point-of-care (POC) testing sites within traditional practices or urgent care centers staffed by one or more physicians. Most of these laboratories implement IVD procedures through one or more portable desktop instruments...Published: December 29, 2022 | Price: $6,000.00 – $12,000.00
Dramatic changes have occurred in the liquid biopsy market, necessitating a resource to provide perspective on the market opportunity. This new report from Kalorama assesses the Liquid Biopsy Market now and in 2027. The report can be useful for business planning, market share assessment, competitive research, and due diligence for mergers and acquisitions and other partnerships. Liquid biopsy is gaining acceptance each year. Even through the COVID-19 pandemic, announcements of new liquid biopsy products were made and studies conducted to...Published: November 17, 2022 | Price: $5,000.00 – $10,000.00
What’s Driving Growth in the IVD Market in Q3 and the last half of 2022? What Major Trends are Affecting the Market in Q3 and the last half of 2022? How Has COVID-19 Impacted and Continued to Impact the Market in Q3 and the last half of 2022? What Product Trends and New Developments Will Shape the IVD Market in the last half of 2022? Diagnostic test products have never been more important. This report is an update of the...Published: November 9, 2022 | Price: $5,000.00 – $10,000.00
The medical device industry, often referred to as the medtech industry, is an important aspect of the entire healthcare industry. The medical device industry is constantly updating and changing through the continued development of new technologies, equipment, tests and devices. Advancements in the medical device markets are life-changing and are allowing patients to live longer, healthier and more productive lives. However, the medical device industry has unique challenges. It is a heavily regulated industry in most nations of the world,...Published: November 3, 2022 | Price: $6,000.00 – $12,000.00
Kalorama Information’s 11th Edition report of the clinical molecular testing industry provides marketing sizing and forecasts for in vitro diagnostics (IVDs) over a five-year period. In this report, our industry experts and top analysts assess the current positions of this complex market, which has an estimated value of more than $21 billion. This data publication has become an indispensable tool in clinical healthcare medicine and assesses the business opportunity, new product introductions, and rapid changes in several areas of this...Published: October 25, 2022 | Price: $5,000.00 – $10,000.00
Despite advances in cancer treatment, cancer continues to affect about 18.1 million people annually, generating a significant loss of life, financial burden and overall strain on the health industry. Worldwide between 35 and 40 million people are living with cancer and nearly 10 million people lose the battle annually. The most common cancers affecting the world population include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder. Cancer deaths occur in about 50% of people who develop cancer in...Published: October 18, 2022 | Price: $5,000.00 – $10,000.00
The Asia Pacific (APAC) region is a fast-growing in vitro diagnostics (IVD) market, which is witnessing increasing focus by leading global players in the market. Southeast Asia has been identified as one of the key regions in APAC region offering significant opportunities for IVD companies. This report focuses on three IVD markets in Southeast Asia: Malaysia, Indonesia, and Singapore. These three countries together represent a fast-growing geographic region offering significant opportunity for IVD companies. The total population of these three...Published: October 6, 2022 | Price: $5,000.00 – $10,000.00
The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. This latest report from Kalorama Information, United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition, discusses the trends shaping the present and future of the IVD...Published: September 23, 2022 | Price: $5,000.00 – $10,000.00
V A C C I N E M A R K E T E X C E E D S $200 B I L L I O N In 2022, the global market for preventive vaccines is valued at $202.6 billion. That's up from $34.1 billion in 2017, and just $25 billion in 2010. Infectious diseases are some of the deadliest diseases that pose significant risk to human life. Sales increased from $127.6 billion in 2021 to $202.6 billion in...Published: September 7, 2022 | Price: $0.00 – $9,000.00
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...Published: September 2, 2022 | Price: $0.00 – $12,000.00
The global in vitro diagnostic (IVD) industry incorporates a sizable contract manufacturing segment that supplies a full range of reagents and test kits, instruments and systems, and testing accessories. Already a multi-billion dollar market, this segment is well positioned to generate favorable long-term growth, as detailed in this report, The Market for Contract Manufacturing in IVD. Most leading worldwide of producers of proprietary IVD systems will increase their reliance on outside contractors as a cost-effective means to: expand existing product...